UK's Medicines and Healthcare products Regulatory Agency (MHRA) is working with the pharmaceutical industry to create user friendly packaging for medicines that are used to treat Alzheimer's disease. The Alzheimer's medicines such as ...
Tags: Dementia Medicines, Packaging
Novartis has obtained the US Food and Drug Administration (FDA) approval for a new 13.3 mg/24 h dosage strength of its Exelon Patch (rivastigmine transdermal system), designed to treat patients with mild to moderate Alzheimer's disease. ...
Tags: Alzheimer's disease, Novartis Pharmaceuticals, Exelon Patch
Teva, a provider of generic pharmaceutical drugs, has introduced Rivastigmine capsules for generic prescription. Rivastigmine is generic equivalent to Novartis' Exelon capsules. Rivastigmine is indicated for use in the symptomatic ...
Tags: Teva, rivastigmine, Novartis'Exelon capsules